BDBM306695 (+-)-N-[(6-amino-2,4-dimethyl- pyridin-3-yl)methyl]-12-(4- fluorophenyl)-10-methyl-15- oxatetracyclo[6.6.1.02,7.09,14] pentadeca-2,4,6,9(14),10,12- hexaene-4-carboxamide and (+-)-N-[(6-amino-2,4- dimethylpyridin-3-yl)methyl]- 11-(4-fluorophenyl)-13- methyl-15-oxatetracyclo [6.6.1.02,7.09,14]pentadeca- 2,4,6,9(14),10,12-hexaene-4- carboxamide::US10144746, Compound 340

SMILES Cc1cc(cc2C3OC(c4ccc(cc34)C(=O)NCc3c(C)cc(N)nc3C)c12)-c1ccc(F)cc1

InChI Key InChIKey=DPSBISUQXKOWEV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 306695   

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandPNGBDBM306695(US10144746, Compound 340 | (+-)-N-[(6-amino-2,4-di...)
Affinity DataIC50: 229nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent